Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-12-22
1991-04-23
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514360, 514365, 514385, 514395, 514869, 514922, 514219, 424 10, A01N 4364, A01N 4382, A01N 4378, A01N 4350
Patent
active
050100920
ABSTRACT:
Drug treatment therapies and kits for use therewith are disclosed. They involve the use of methimazole and/or its pro-drug carbimazole to reduce nephrotoxic effects of chemical exposure. In one embodiment, a patient receives cisplatin and then is treated with methimazole. The time delay in providing methimazole prevents the methimazole from being substantially expelled by the kidney prior to cisplatin reaching the kidney.
REFERENCES:
patent: 4526888 (1985-07-01), Williams et al.
patent: 4581224 (1986-04-01), Borch
patent: 4645661 (1987-02-01), Schonbaum
patent: 4919917 (1990-04-01), Kakimoto et al.
L. Ramsammy et al., 238, J. Pharm. Exper. Thero., 83-88.
B. Marchant et al., 91, Endo., 747-756, (1972).
T. Zenser et al., 227, J. Pharm. Ex. Ther. 545-550, (1983).
T. Petry et al., 262, J. Bio. Chem., 14112-14118, (1987).
R. Schnellmann et al., 237, J. Pharm. Ex. Ther., 456-461, (1986).
S. Lau et al., 15, Drug Metab. and Disp., 801-807, (1987).
R. Schnellmann, 99, Tox. and App. Pharm., 11-18, (1989).
J. Burchenal et al., 60, Biochimie, 961-965, (1978).
J. Filipski et al., 204, Science, 181-183, (1979).
J. Yuhas et al., 64, Can. Treat. Rep., 57-64, (1980).
S. Howell et al., 43, Can. Res., 1426-1431, (1983).
C. Kuo et al., 67, Tox and App. Pharm., 78-88, (1983).
A. Elfarra et al., 33, Biochem. Pharm., 3729-3732, (1984).
A. Elfarra et al., 233, J. Pharm. and Ex. Ther., 512-516, (1985).
L. Ramsammy et al., 34, Biochem. Pharm., 3895-3900, (1985).
P. Williams et al., 237, J. Pharm. and Ex. Ther., 919-925, (1986).
P. Dedon et al., 36, Biochem. Pharm., 1955-1964, (1987).
S. Heyman et al., 82, J. Clin. Invest., 401-412, (1988).
R. Qazi et al., 80, J. Nat. Can. Inst., 1486-1492, (1988).
B. Tune et al., 38, Biochem. Pharm., 795-802, (1989).
J. Cohen et al., 36, Kidney Inter., 730-740, (1989).
B. Marchant et al., Endo., vol. 91, pp. 747-756, (1972).
T. Zenser et al., J. Pharm. Ex. Ther.; vol. 227, pp. 545-550, (1983).
A. Elfarra et al.; Biochem. Pharm.; vol. 33, pp. 3729-3732, (1984).
L. Ramsammy et al., vol. 34, Biochemical Pharmacology, pp. 3895-3900, (1985).
Criares T.
Friedman Stanley J.
Wisconsin Alumni Research Foundation
LandOfFree
Protection against chemically-induced kidney damage by methimazo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protection against chemically-induced kidney damage by methimazo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protection against chemically-induced kidney damage by methimazo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1621602